Eric Snyder

Eric Snyder is a Partner in Venture Investments at Novo Holdings since January 2022, with extensive experience in board roles across various healthcare and technology companies. Currently, Eric serves on the boards of Magenta Medical Ltd., Nalu Medical, Inc., and FIRE1 Foundry, while also holding observer roles at Octave and Deep 6 AI. Additionally, Eric's previous board experience includes positions at Disc Medicine, PROTHELIA INCORPORATED, and F2G, among others. Eric holds a PhD in Neuroscience from Brown University and completed a program on Leading Digital Transformation in Health Care at Harvard Medical School in 2020.